Protagonist Therapeutics, Inc
Protagonist Therapeutics, Inc (PTGX) is a publicly traded company in the Unknown sector. Across all available filings, 22 corporate insiders have executed 234 transactions totaling $58.0M, demonstrating a bullish sentiment with $13.0M in net insider flow. The most recent transaction on Jan 27, 2026 involved a transaction of 5,000 shares valued at $0.
PTGX Insider Activity Summary
Who Is Buying PTGX Stock?
No significant insider buying has been recorded for PTGX in the recent period.
Who Is Selling PTGX Stock?
No significant insider selling has been recorded for PTGX in the recent period.
Is Protagonist Therapeutics, Inc Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for PTGX is bullish with an Insider Alignment Score of 61/100 and a net flow of $13.0M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
PTGX Frequently Asked Questions
Understanding PTGX Insider Activity
Insider trading at Protagonist Therapeutics, Inc (PTGX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 22 insiders are actively trading PTGX stock, having executed 234 transactions in the past 90 days. The most active insider is Dinesh V. Ph D. Patel (Executive), who has made 60 transactions totaling $11.1M.
Related Tools
Track Protagonist Therapeutics, Inc Insider Activity
Get notified when executives and directors at PTGX file new Form 4 transactions